Skip to main content
. 2021 Nov 13;11(11):1199. doi: 10.3390/jpm11111199

Figure 5.

Figure 5

The role of TP53 and CTNNB1 gene statuses in the paclitaxel drug sensitivity in hepatocellular carcinoma cells. The paclitaxel drug activity in HCC cell lines according to the TP53 mutation status (A, left), CTNNB1 mRNA expression (A, right), or their combination (B).